FindTrial
Sign In

Simplified immune-dysregulation index (IL-6/lymphocyte) as a predictor of short-term prognosis in septic patients

Immune dysregulation-based assessment system for short-term prognosis in patients with sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058880
Enrollment
Unknown
Registered
2022-04-18
Start date
2022-04-30
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Case series:None

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of sepsis shall refer to the diagnostic criteria of Sepsis and Septic Shock (Third Edition) (Sepsis 3.0 diagnostic criteria) in 2016; 2. Age>18, regardless of gender; 3. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Blood system diseases; 2. Tumor patients; 3. Patients receiving glucocorticoid or immunosuppressive therapy recently.

Design outcomes

Primary

MeasureTime frame
IL-6/LY;28-day mortality;—

Secondary

MeasureTime frame
SOFA score;—

Countries

China

Contacts

Public ContactWang Jun

The First Affiliated Hospital of Soochow University

dr_wangjun@suda.edu.cn+86 18606278680

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026